Literature DB >> 14686978

Mycosis fungoides: radiation therapy.

Richard T Hoppe1.   

Abstract

Radiation therapy is the most effective single agent for the treatment of mycosis fungoides. There are well-defined dose-response relationships for achieving a complete response as well as the durability of this response. Techniques of electron beam therapy have been developed that permit treatment of the entire skin. Total-skin electron beam therapy is an important form of management, especially for patients who have thick generalized plaque or tumorous disease. Radiation therapy may also be used selectively for treatment of extracutaneous disease.

Entities:  

Mesh:

Year:  2003        PMID: 14686978     DOI: 10.1111/j.1396-0296.2003.01647.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  19 in total

Review 1.  The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications.

Authors:  Ercole Mazzeo; Laura Rubino; Michela Buglione; Paolo Antognoni; Stefano Maria Magrini; Francesco Bertoni; Manuela Parmiggiani; Paola Barbieri; Filippo Bertoni
Journal:  Rep Pract Oncol Radiother       Date:  2013-08-13

2.  Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis Fungoides.

Authors:  John T O'Malley; Adele de Masson; Elizabeth L Lowry; Anita Giobbie-Hurder; Nicole R LeBoeuf; Cecilia Larocca; Ahmed Gehad; Edward Seger; Jessica E Teague; David C Fisher; Thomas S Kupper; Phillip M Devlin; Rachael A Clark
Journal:  Clin Cancer Res       Date:  2019-10-21       Impact factor: 12.531

Review 3.  Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome.

Authors:  Sara Berg; Jennifer Villasenor-Park; Paul Haun; Ellen J Kim
Journal:  Curr Hematol Malig Rep       Date:  2017-06       Impact factor: 3.952

4.  Total skin electron therapy for cutaneous T-cell lymphoma using a modern dual-field rotational technique.

Authors:  Thatcher R Heumann; Natia Esiashvili; Sareeta Parker; Jeffrey M Switchenko; Anees Dhabbaan; Michael Goodman; Mary Jo Lechowicz; Christopher R Flowers; Mohammad K Khan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-02-07       Impact factor: 7.038

Review 5.  Clinical results of the total skin electron irradiation of the mycosis fungoides in adults. Conventional fractionation and low dose schemes.

Authors:  Joanna Kaźmierska
Journal:  Rep Pract Oncol Radiother       Date:  2013-09-26

Review 6.  Literature review of clinical results of total skin electron irradiation (TSEBT) of mycosis fungoides in adults.

Authors:  Fabio Ynoe de Moraes; Heloisa de Andrade Carvalho; Samir Abdallah Hanna; João Luis Fernandes da Silva; Gustavo Nader Marta
Journal:  Rep Pract Oncol Radiother       Date:  2013-09-27

7.  Acral erosive mycosis fungoides: successful treatment with localised radiotherapy.

Authors:  Connie Mengyan Wang; Madeleine Duvic; Bouthaina Shbib Dabaja
Journal:  BMJ Case Rep       Date:  2013-04-16

8.  Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma.

Authors:  Wen-Kai Weng; Sally Arai; Andrew Rezvani; Laura Johnston; Robert Lowsky; David Miklos; Judith Shizuru; Lori Muffly; Everett Meyer; Robert S Negrin; Erica Wang; Timothy Almazan; Lynn Million; Michael Khodadoust; Shufeng Li; Richard T Hoppe; Youn H Kim
Journal:  Blood Adv       Date:  2020-09-22

9.  Total skin electron beam therapy for primary cutaneous T-cell lymphomas: clinical characteristics and outcomes in a Mexican reference center.

Authors:  Ch Flores-Balcázar; D M Urías-Arce; Y Charli-Joseph; M A De León-Alfaro; S I Pérez-Álvarez; R Ramos-Prudencio
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-27

10.  Treating cutaneous T-cell lymphoma with highly irregular surfaces with photon irradiation using rice as tissue compensator.

Authors:  Lonika Majithia; Yi Rong; Farzan Siddiqui; Todd Hattie; Nilendu Gupta; Michael Weldon; Arnab Chakravarti; Henry K Wong; Pierluigi Porcu; Meng Xu-Welliver
Journal:  Front Oncol       Date:  2015-02-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.